Hirsch Daniel J.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
RC Refinancing More Complex Than Expected. Ready Capital’s recent refinancing plans are proving less straightforward than initially reported. The company’s debt restructuring details suggest additional costs and timing uncertainties that could impact cash flow. This development may affect investor sentiment and short‑term trading activity.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Envoy Medical Adds Two New Patents to Global Portfolio. Envoy Medical announced it has been granted two additional global patents, further expanding its intellectual property portfolio. This development strengthens the company's protection for its medical technologies. The stock is currently trading near its 52-week low, with an average analyst target of $2.00.
Transaction History
| MAC | ▲ Buy | Grant | 6,720 | $0 | 6/1/2026 | View on chart |
| MAC | ▲ Buy | Grant | 8,348 | $0 | 6/2/2025 | View on chart |
| MAC | ▲ Buy | Grant | 9,103 | $0 | 5/30/2024 | View on chart |
| RC | ▲ Buy | Grant | 12,693 | $0 | 2/22/2024 | View on chart |
| COCH | ▼ Sell | Other | 25,000 | $0 | 9/29/2023 | View on chart |
| RC | ▲ Buy | Grant | 6,545 | $0 | 6/1/2023 | View on chart |
| MAC | ▲ Buy | Grant | 14,004 | $0 | 5/31/2023 | View on chart |
| MAC | ▲ Buy | Grant | 11,421 | $0 | 5/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Truist Securities initiates coverage on Macerich with Buy rating
Truist Securities has initiated coverage on Macerich with a Buy rating and a $26 price target. This move adds to the analyst consensus, which currently averages $27.00 across 15 analysts. The stock currently offers a dividend yield of 6.19%, a factor often considered by income-focused investors.
Truist Securities initiates coverage on Macerich with Buy rating. Truist Securities has initiated coverage on Macerich with a Buy rating and a $26 price target. This move adds to the analyst consensus, which currently averages $27.00 across 15 analysts. The stock currently offers a dividend yield of 6.19%, a factor often considered by income-focused investors.